Molecular imaging to identify tumor recurrence following chemoradiation in a hostile surgical environment

Molecular Imaging
|December 3, 2014
PubMed

Insights

Targeted fluorescent molecular imaging helps surgeons precisely biopsy recurrent lung cancer in difficult surgical fields. This technique identifies viable tumor deposits missed by standard methods, improving diagnostic accuracy.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Molecular Imaging

Background:

  • Accurate diagnosis of recurrent cancer after treatment is challenging due to imaging limitations in post-surgical/radiation fields.
  • Definitive tissue diagnosis is crucial for guiding cancer treatment and therapy.
  • Current methods struggle to differentiate recurrent tumors from scar tissue and necrosis.

Observation:

  • A folate-fluorescein conjugate was used for intraoperative molecular imaging in a patient with suspected recurrent lung adenocarcinoma.
  • The imaging technique was applied in a "hostile" surgical field previously treated with chemoradiation.
  • The technique aimed to assist surgical biopsy by highlighting tumor recurrence.

Findings:

  • Intraoperative molecular imaging successfully identified small, viable tumor deposits.
  • These deposits were previously indistinguishable from scar tissue and necrosis on conventional imaging.
  • Histology, fluorescence microscopy, and immunohistochemistry confirmed the imaging findings.

Implications:

  • Intraoperative molecular imaging offers a valuable tool for surgical biopsy in complex oncological cases.
  • This technique can improve the accuracy of diagnosing tumor recurrence in challenging clinical scenarios.
  • It demonstrates potential clinical value for guiding cancer therapy and patient management.

Related Concept Videos